SITPIN D 10/50

SITPIN D 10/50 contains Sitagliptin 50 mg + Dapagliflozin 10 mg, a modern combination therapy for effective type 2 diabetes management. Sitagliptin helps enhance insulin release after meals, while Dapagliflozin works by removing excess glucose through urine. Together, they provide better blood sugar control, support improved HbA1c levels, and help patients maintain stable glucose balance as part of long-term diabetes care.